ClinicalTrials.Veeva

Menu

Alere Mycobacterium Tuberculosis Urine Study

R

Research Center Borstel

Status

Completed

Conditions

Tuberculosis

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01585532
CLDG-0402 (Other Identifier)
RCBorstel002

Details and patient eligibility

About

Current molecular methods will be evaluated for the detection of Mycobacterium tuberculosis specific nucleic acid in urine and blood of patients.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Suspected or confirmed tuberculosis
  • Age >18 years
  • informed consent obtained

Exclusion criteria

  • Previous participation in the study
  • Simultaneous participation in a clinical trial investigating a new drug
  • Inability to give consent
  • Member of a vulnerable study population

Trial design

60 participants in 2 patient groups

TB suspects with alternative final diagnosis
Confirmed tuberculosis patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems